RxDoctor Payments Data

Jon Fox, PA

Physician Assistant · Boise, IDNPI 1447221932

Payments from drug & device makers

$2,798in general payments, 2019–2025

Across 168 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$442
  • Novo Nordisk$244
  • Novartis$161
  • Mayne Pharma Commercial LLC$139
  • AstraZeneca$128
  • plus $570 from 16 others

What the payments were for

  • Food & beverage$2,798100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,798 in reported general payments places this provider in the 85th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$22,703
Medicare patients
90
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol70$47,644
EliquisApixaban58$45,128
TrulicityDulaglutide32$37,676
JardianceEmpagliflozin31$30,418
MounjaroTirzepatide11$22,932
MyrbetriqMirabegron21$14,775
JanuviaSitagliptin Phosphate12$7,082
TrexallMethotrexate Sodium11$4,411
Levothyroxine Sodium253$3,028
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$2,661
Omeprazole125$2,470
Atorvastatin Calcium196$1,716
Gabapentin102$1,653
Albuterol Sulfate HfaAlbuterol Sulfate60$1,610
Lisinopril207$1,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$64$60,60743 claims
AstraZenecaFarxiga$128$47,64470 claims
PfizerEliquis$90$45,12858 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →